Unigene Laboratories, Inc. States That New Government Study Reports That Many Osteoporosis Medications Prevent Fractures, but None is Proven Best

FAIRFIELD, N.J.--(BUSINESS WIRE)--Unigene Laboratories, Inc. (OTCBB: UGNE) reports that a comparative analysis of various osteoporosis therapies has been published, concluding that there is insufficient evidence to support claims of superior effectiveness among the drugs reviewed.